Cheryl L. Quinn - Concepedia

Author

Cheryl L. Quinn

Cubist Pharmaceuticals (United States)

Also Known As

C L Quinn, C. L. QUINN, C.L. Quinn, Cheryl L. Quinn, Cheryl Quinn

Publications

627

Citations

H-Index

Concepts

All Affiliations

Cubist Pharmaceuticals (United States)John Radcliffe Hospital

About

Cheryl L. Quinn is an author at Cubist Pharmaceuticals (United States) specializing in natural sciences, medicine, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	152
2	Natural Sciences	4	4	267
3	Biochemistry	3	3	100
4	Engineering	1	1	147
5	Biology	1	1	52

Cheryl L. Quinn

Publications

597

Citations

H-Index

Page 1

	Year	Citations
Functional organization and nucleotide sequence of the Bacillus subtilis pyrimidine biosynthetic operon Cheryl L. Quinn, B.T. Stephenson, Robert L. Switzer Journal of Biological Chemistry Bacillus SubtilisBiosynthesisEngineeringFunctional OrganizationPhylogenetic Analysis	1991	147
Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain. Miles P. Davenport, Cheryl L. Quinn, Roman M. Chicz, Proceedings of the National Academy of Sciences	1995	110
Novel Riboswitch-Binding Flavin Analog That Protects Mice against Clostridium difficile Infection without Inhibiting Cecal Flora Ken Blount, Cynthia M. Megyola, Mark S. Plummer, Antimicrobial Agents and Chemotherapy	2015	100
Mass spectrometric identification of ligands selected from combinatorial libraries using gel filtration Yuriy M. Dunayevskiy, Jan‐Ji Lai, Cheryl L. Quinn, Rapid Communications in Mass Spectrometry Combinatorial LibrariesBiological Mass SpectrometryActive LigandsChemistrySpectrochemical Analysis	1997	52
Evidence that two present-day components needed for the genetic code appeared after nucleated cells separated from eubacteria. Lluı́s Ribas de Pouplana, Magali Frugier, Cheryl L. Quinn, Proceedings of the National Academy of Sciences GeneticsMolecular GeneticsGenomicsPhylogenetic AnalysisBiosynthesis	1996	52
Species-specific microhelix aminoacylation by a eukaryotic pathogen tRNA synthetase dependent on a single base pair Cheryl L. Quinn, Nianjun Tao, Paul Schimmel Biochemistry	1995	50
Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC Joseph S. Warmus, Cheryl L. Quinn, Clarke Taylor, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineRational Drug DesignP. Aeruginosa LpxcAntibacterial Agent	2012	32
Characterization of <scp>d</scp>‐boroAla as a Novel Broad‐Spectrum Antibacterial Agent Targeting <scp>d</scp>‐Ala‐<scp>d</scp>‐Ala Ligase Sandeep Putty, Aman Rai, Darshan Jamindar, Chemical Biology & Drug Design D-ala-d-ala Ligase EnzymesAntibacterial ActivityEscherichia ColiAntimicrobial ChemotherapyDrug Resistance	2011	16
Deletion of Individual mRNA Capping Genes Is Unexpectedly Not Lethal to <i>Candida albicans</i> and Results in Modified mRNA Cap Structures D S Dunyak, Daniel S. Everdeen, Joseph G. Albanese, Eukaryotic Cell	2002	14
Expression and function of HLA‐B27 in lipid‐linked form: Implications for cytotoxic T lymphocyte‐induced apoptosis signal transduction Xiaoming Gao, Cheryl L. Quinn, John I. Bell, European Journal of Immunology	1993	12

Page 1